Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Valentina, Tefanova"'
Autor:
Riina Salupere, Valentina Tefanova, Tatiana Kuznetsova, Vadim Brjalin, Ljudmilla Priimägi, Tatjana Tallo
Publikováno v:
Open Medicine, Vol 8, Iss 6, Pp 822-829 (2013)
Background The aim of the study was to analyse the predictive host and viral factors of sustained virological response (SVR) in Estonian patients with chronic hepatitis C genotype 1b.
Autor:
Olga Katargina, Michail Michailov, Valentina Tefanova, Helene Norder, Jelena Schmidt, Lars O. Magnius, Tatjana Tallo, Ljudmilla Priimägi, Sergey Mukomolov
Publikováno v:
Journal of General Virology. 89:1829-1839
Complete or almost complete hepatitis B virus (HBV) genomes were sequenced for 13 genotype A and 42 genotype D strains from the former USSR. The strains were classifiable within subgenotypes A2, D1, D2 and D3. Comparison of the deduced gene products
Autor:
Kaije Pruunsild, Tõnu Krispin, Karen Orgulas, Valentina Tefanova, Lars O. Magnius, Ludmilla Priimägi, Tatjana Tallo, Madis Ilmoja, Jelena Schmidt, Helene Norder
Publikováno v:
Journal of Medical Virology. 79:374-382
During the last decade, there has been a dramatic increase in intravenous drug use in young adults in Estonia with an increased incidence of both hepatitis B and C as a consequence. Since genetic data are limited regarding hepatitis C virus (HCV) str
Autor:
Anna O. Ivanova, Brian Lassen, Marilin Janson, Kädi Neare, Kaisa Velström, Pikka Jokelainen, Tatiana Kuznetsova, Julia Geller, Pirje Hütt, Irina Golovljova, Åke Lundkvist, T. Saar, Valentina Tefanova, Arvo Viltrop, Irina Reshetnjak
Publikováno v:
Food and environmental virology. 7(4)
While hepatitis E is a growing health concern in Europe, epidemiological data on hepatitis E virus (HEV) in Estonia are scarce. Along with imported HEV infections, autochthonous cases are reported from European countries. Both domestic and wild anima
Autor:
Irina Golovljova, Åke Lundkvist, Anna O. Ivanova, Olga Katargina, Valentina Tefanova, Sirkka Vene, Julia Geller, Kairi Värv
Publikováno v:
Ticks and tick-borne diseases. 6(6)
A total of 1640 ticks collected in different geographical parts of Estonia were screened for the presence of Rickettsia species DNA by real-time PCR. DNA of Rickettsia was detected in 83 out of 1640 questing ticks with an overall prevalence of 5.1%.
Autor:
Valentina Tefanova, Tõnu Krispin, M. I. Mikhailov, Ludmilla Priimägi, Helene Norder, Lars O. Magnius, Tatjana Tallo, Sergey Mukomolov
Publikováno v:
Journal of Medical Virology. 74:221-227
The genotypes and subtypes of 205 HBV isolates collected during 1989-2002 in Estonia and 14 other regions of the former USSR were determined by sequencing and phylogenetic analysis of the S gene. The in Europe prevailing genotypes, A and D, were also
Autor:
Valentina Ustina, Tatjana Tallo, Ludmilla Priimägi, Jelena Schmidt, Tiina Prükk, Olga Solomonova, Lars O. Magnius, Kai Zilmer, Helene Norder, Kristi Ott, Tõnu Krispin, Valentina Tefanova
Publikováno v:
Journal of Medical Virology. 70:187-193
Hepatitis A virus (HAV) isolates from a large outbreak and from non-outbreak cases in Estonia were characterized by sequencing the aminoterminal VP1 region. From January 1998 to December 1999, a total of 1084 cases of hepatitis A were reported to the
Autor:
Ljudmilla Priimägi, Riina Salupere, Irina Reshetnjak, Valentina Tefanova, Maria Smirnova, Juris Jansons, Tatiana Kuznetsova, Tatjana Tallo, Olga Katargina, Vadim Brjalin
Publikováno v:
Hepatitis Monthly
Background A substantial proportion of hepatitis C virus (HCV)-1b infected patients do not response to pegylated interferon-α plus ribavirin (PegIFNα/RBV) combination therapy that was partially associated with mutations in the non-structural 5A (NS
Several case reports deal with the relationship between hepatitis C virus (HCV) infection and pulmonary or hepatic sarcoidosis. Most publications describe interferon α-induced sarcoidosis. However, HCV infection per se is also suggested to cause sar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de2f1ae14efc71ffa35c01c596f6335
https://europepmc.org/articles/PMC3484354/
https://europepmc.org/articles/PMC3484354/
Autor:
Valentina Tefanova, Ljudmilla Priimägi, Riina Salupere, Tatjana Tallo, Vadim Brjalin, Tatiana Kuznetsova
Publikováno v:
Central European journal of public health. 20(2)
Aim: The aim of the study was to assess the efficacy of pegylated interferon (Peg-IFN) α-2a and ribavirin (RBV) combination therapy in treatment-naive patients with chronic hepatitis C in Estonia. Methods: Out of 121 outpatients with chronic hepatit